1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Metagenomi director Brian C. Thomas resigned from the board effective June 9, 2026, with the company saying the resignation involved no disagreement on its operations, policies or practices. At the same day's annual meeting, shareholders re-elected... elected Juergen Eckhardt and Eric Bjerkholt as Class II directors and ratified PricewaterhouseCoopers LLP as auditor for 2026.
Brian C. Thomas resigned from the Board effective June 9, 2026; the filing states no disagreement with the company.
Juergen Eckhardt received 7,296,718 votes for and 1,436,882 withheld; Eric Bjerkholt received 8,251,289 for and 482,311 withheld.
Shareholders ratified PricewaterhouseCoopers LLP for fiscal 2026 with 18,483,295 for, 51,847 against and 581,065 abstentions.
Shares present or represented were 19,116,207 of 37,647,057 outstanding and entitled to vote, establishing a quorum.
Maui Land & Pineapple Company, Inc. appointed Ryan Panopio as its newly created Chief Investment Officer, effective June 3, 2026. The filing says the role is meant to optimize the company's land development pipeline and guide its capital deployment strategy, and it sets out his base salary and incentive targets.
Appointment effective June 3, 2026; the Chief Investment Officer role is newly created.
Annual base salary of $380,000, with an annual incentive target of 50% of salary and a long-term incentive target of 90% of salary.
Mr. Panopio, age 46, most recently served as Head of Capital Markets, Americas at Lendlease Group from October 2023 to January 2026.
Full offer letter will be filed as an exhibit to the Form 10-Q on or before August 14, 2026.
Enveric Biosciences filed a prospectus supplement on June 9, 2026, to offer an additional $2,425,000 of common stock through its existing at-the-market sales agreement with H.C. Wainwright & Co. The company has previously sold $4,483,711.04 of shares under that agreement, which dates to April 9, 2025. The filing adds to potential dilution for existing shareholders, but it does not disclose a financial result or a change in business operations.
Additional offering amount: $2,425,000 of common stock under the ATM Agreement dated April 9, 2025
Sales to date under the ATM Agreement before this filing: $4,483,711.04
Sales agent: H.C. Wainwright & Co., LLC; legal opinion filed as Exhibit 5.1 from Greenberg Traurig, LLP
PTC Therapeutics director Alethia Young resigned from the board effective June 8, 2026, citing commitments to other work activities and not any disagreement with the company. She will remain as an advisor under a consulting agreement running through June 8, 2027, for a monthly fee of $4,166.67.
Alethia Young resigned from the board of directors effective June 8, 2026.
Resignation was stated to be due to her need to focus on other work commitments, not a disagreement with the company.
Consulting agreement runs June 8, 2026 through June 8, 2027, at $4,166.67 per month (Exhibit 10.1).
Fifth District Bancorp, Inc. appointed Donna T. Guerra to its Board of Directors and to the board of its bank subsidiary, Fifth District Savings Bank, on June 8, 2026. Her term runs in the class expiring in 2027, and the board has not yet decided which committees she will join.
Appointed June 8, 2026 to the Company's board, in the class with terms expiring in 2027
Also appointed to the board of Fifth District Savings Bank
Holds a CPA certification and is a Chartered Global Management Accountant (CGMA)
Currently Director of Terminal Services at Canal Terminal Company; previously held 13 years at Hibernia Bancorp, including Chief Financial Officer
Teleflex's independent directors approved a special restricted stock unit award with a grant date fair value of $600,000 for Stuart A. Randle, who is serving as Interim President and Chief Executive Officer. The board said the award recognizes his work in that role, including operational, governance and investor relations matters and the company's search for a permanent CEO, and that he has served longer than initially expected.
Award: special restricted stock units with grant date fair value of $600,000 to Stuart A. Randle
Grant date: June 8, 2026; approved by independent directors on recommendation of the Compensation Committee
Vesting: earlier of June 8, 2027 or the date of the 2027 annual meeting of stockholders
Company is still searching for a permanent President and Chief Executive Officer
At its June 4, 2026 annual meeting, Talos Energy stockholders approved the Second Amended and Restated 2021 Long Term Incentive Plan, which adds 4,500,000 shares to the plan's share reserve and extends the plan term to the tenth anniversary of the meeting. Stockholders also elected six directors, approved executive pay on an advisory basis, and ratified Ernst & Young LLP as auditor. The larger share reserve means more shares can be issued under the plan, which can dilute existing holders.
Share reserve rises by 4,500,000 shares, from 12,439,415 to 16,939,415, subject to share recycling and adjustment provisions
Plan approved at the June 4, 2026 annual meeting and effective that day; term extended to the tenth anniversary of the meeting
Paula R. Glover's board term expired at the meeting, and the board was reduced from seven to six directors
Ernst & Young LLP ratified as independent auditor for the fiscal year ending December 31, 2026
At its June 9, 2026 annual meeting, Ulta Beauty stockholders elected all 10 director nominees, approved a new 2026 Incentive Award Plan, and approved amendments to the certificate of incorporation covering officer exculpation and exclusive forum provisions. The plan authorizes up to 5,001,201 shares, including 3,500,000 newly authorized shares, which shareholders should weigh as potential dilution. Most proposals passed with strong support, while the executive compensation advisory vote drew 22.02% against.
The 2026 Plan authorizes up to 5,001,201 shares: 3,500,000 new shares plus 1,501,201 remaining under the Prior Plan as of April 13, 2026.
Executive compensation advisory vote: 77.83% for, 22.02% against.
Ernst & Young LLP ratified as independent auditor for fiscal 2026, ending January 30, 2027, with 88.08% for.
Lorna E. Nagler and Gisel Ruiz received the lowest director support at 94.21% and 94.62% for, respectively.
Novanta agreed on June 8, 2026 to sell 2,142,857 common shares at $140.00 each in a private placement to institutional and accredited investors, for an aggregate purchase price of approximately $300.0 million before placement agent fees and expenses. The closing is expected on June 11, 2026, subject to customary conditions, and the company agreed to register the resale of the shares, which would add to the share count for existing holders.
Purchase price: $140.00 per share, 2,142,857 shares, about $300.0 million aggregate
Expected closing on or about June 11, 2026, subject to customary closing conditions
Post-closing count: 42,473,345 common shares outstanding or issuable under Tangible Equity Units, based on 35,613,303 shares outstanding as of June 8, 2026
Registration statement due within 30 days after closing; placement agents include J.P. Morgan Securities LLC and PNC Capital Markets LLC
Arch Capital Group completed a public offering of $2.0 billion in senior unsecured notes, split into $600 million due 2036 at 5.250% and $1.4 billion due 2056 at 5.950%. The notes add to the company's debt load, with interest paid semi-annually and the notes ranking behind obligations of its subsidiaries.
$600 million of 5.250% senior notes due June 15, 2036, and $1.4 billion of 5.950% senior notes due June 15, 2056
Interest is payable semi-annually on June 15 and December 15, starting December 15, 2026
Notes are effectively subordinated to obligations of the company's subsidiaries, including insurance and reinsurance policy obligations, and are not guaranteed by them
Notes were issued under a universal shelf registration on Form S-3 and a Third Supplemental Indenture dated June 9, 2026, with The Bank of New York Mellon as trustee
QuasarEdge Acquisition Corp, a special purpose acquisition company listed on the NYSE, signed a merger agreement with Robseek Intelligence Inc., a Cayman Islands AI technology company. The Company's shareholders would receive 100,000,000 shares of the post-merger listed company, valued at $10.00 per share, based on a pre-money equity valuation of $1 billion, and the deal remains subject to shareholder and SEC approvals and other closing conditions.
Pre-money equity valuation of Robseek set at $1,000,000,000; 100,000,000 Purchaser ordinary shares valued at $10.00 per share
Immediately after closing, Purchaser's board is expected to have seven directors: one designated by QuasarEdge and six by Robseek
Closing requires shareholder approvals, SEC effectiveness of the registration statement, and stock exchange listing approval
Certain shareholders are expected to sign lock-up agreements restricting transfers for 180 days after closing
At its June 9, 2026 annual meeting, Innovative Industrial Properties stockholders approved a 2026 Omnibus Incentive Plan that replaces the 2016 plan, which has been terminated for new grants but still governs outstanding awards. The new plan allows up to 1,250,000 shares of common stock to be issued for awards, which matters to shareholders because it sets the share capacity for equity-based pay. Stockholders also elected five directors, ratified BDO USA as auditor, and gave a split vote on the advisory say-on-pay proposal.
The 2026 plan permits up to 1,250,000 common shares for awards, subject to adjustments and share counting rules.
Five directors were elected, including Alan Gold with 15,158,881 votes for and Scott Shoemaker with 10,281,923 votes for.
Advisory say-on-pay received 10,666,254 votes for and 6,025,986 votes against, and stockholders preferred a one-year frequency with 16,097,437 votes.
Casey's reported fourth-quarter diluted EPS of $4.37, up from $2.63 a year earlier, with net income of $162.7 million, driven by higher inside and fuel gross profit. For fiscal 2026, diluted EPS was $19.16 and EBITDA was nearly $1.5 billion, and the company guided fiscal 2027 EBITDA growth of 8% to 10%. The board also expanded the share repurchase authorization to $1 billion from $400 million, which bears directly on shareholder returns.
Q4 fiscal 2026 diluted EPS $4.37, up 66.2%; net income $162.7 million, up 65.5%
Fiscal 2026 diluted EPS $19.16, up 30.9%; net income $714.4 million, up 30.7%
Share repurchase authorization expanded to $1 billion from $400 million, effective June 4, 2026
Quarterly dividend raised 14% to $0.65 per share, payable August 14, 2026
Affiliated Managers Group entered a Fourth Amended and Restated Credit Agreement on June 9, 2026, providing a $1.25 billion senior unsecured revolving credit facility with Bank of America as administrative agent. It replaces the company's prior credit agreement dated November 15, 2024, and borrowings may fund general corporate purposes, including repurchases of common stock and cash dividends.
Facility size is $1.25 billion, maturing June 9, 2031
Company may increase commitments by up to $750 million, subject to conditions
Covenants include leverage and interest coverage financial tests, plus limits on priority debt, asset sales and fundamental changes
On June 8, 2026, Ingredion agreed with Tate & Lyle's board on a recommended all-cash acquisition of Tate & Lyle at 595 pence per share, with cash consideration of about £2.7 billion (about $3.6 billion) and an implied enterprise value of about $5.0 billion. Ingredion plans to fund the deal with existing cash, new debt and, if needed, a 364-day bridge loan, and expects pro forma net leverage of about 3.0x net debt-to-adjusted EBITDA at completion. The deal is expected to close in the second half of 2027, subject to Tate & Lyle shareholder and court approval and antitrust conditions, and Ingredion expects it to be adjusted EPS accretive in the first year.
Tate & Lyle shareholders would receive 595 pence in cash per share, about a 59% premium to the May 13, 2026 closing price.
Cash consideration is about £2.7 billion (about $3.6 billion); implied enterprise value is about £3.7 billion ($5.0 billion).
Ingredion expects pro forma net leverage of about 3.0x at completion and about 2.5x within about 18 months.
Expected run-rate net cost synergies of about $130 million by the end of 2030, against one-time costs of about $175 million.
On June 5, 2026, the company's operating partnership bought the Waterford Loan from NexBank Capital for $27.2 million, funded with borrowings under its revolving credit facility. The loan is a 10.00% fixed-rate term loan tied to the acquisition of a 240-unit multifamily property in North Carolina, and it marks the company's first deployment in its DST bridge-lending program. Because a director and officer of the company has ties to NexBank Capital and to the external adviser, the deal is a related-party transaction.
Purchase price of $27.2 million equal to outstanding principal plus accrued interest, funded through the revolving credit facility with JPMorgan Chase Bank, N.A.
Fixed interest rate of 10.00% per year, compounded monthly, with a stated maturity of January 14, 2028 and a 364-day extension option.
Loan bought without recourse except for breaches of representations; NexBank Capital must repurchase it if a material breach is not cured within 30 days, and claims survive 360 days.
A director and officer is a director of NexBank Capital and is linked to the parent of the external adviser, NexPoint Real Estate Advisors, L.P.
Lakeland Industries reported fiscal first quarter 2027 results for the period ended April 30, 2026. Net sales rose 1.4% to $47.4 million and net income was $0.4 million, compared with a net loss of $3.9 million a year earlier, but the profit swing reflects a $6.5 million gain on the sale of HPFR and HiViz product lines, while gross profit fell 4.9%.
Net sales were $47.4 million, up $0.7 million or 1.4% from $46.7 million in Q1 FY26.
Gross profit was $14.9 million, down $0.8 million or 4.9% from $15.6 million.
Net income was $0.4 million versus a net loss of $3.9 million, and the reconciliation includes a $6.5 million gain on sale of certain assets recorded in March 2026.
Adjusted EBITDA excluding FX was $1.1 million, compared with $0.6 million; borrowings under the revolving credit facility were $23.8 million as of April 30, 2026.
Cracker Barrel reported fiscal third-quarter 2026 revenue of $797.4 million, down 2.9% from a year earlier, and GAAP diluted earnings of $1.90 per share, which include a $47.4 million litigation settlement benefit. Excluding non-GAAP adjustments, adjusted diluted earnings were $0.29 per share versus $0.58 a year earlier, and adjusted EBITDA was $40.3 million versus $48.1 million. The company raised its fiscal 2026 revenue and adjusted EBITDA outlook, which is the main positive for shareholders.
Q3 total revenue $797.4 million, down 2.9%; comparable store restaurant sales down 2.6%
GAAP diluted EPS $1.90 vs $0.56; adjusted diluted EPS $0.29 vs $0.58
Fiscal 2026 adjusted EBITDA outlook raised to $120 million to $125 million from $85 million to $100 million
Fiscal 2026 revenue outlook raised to $3.27 billion to $3.30 billion from $3.24 billion to $3.27 billion
Wendy's Chief Accounting Officer Suzanne Thuerk has given notice she will resign to pursue an opportunity outside the restaurant industry. Vice President – Tax Aaron Kale was appointed Chief Accounting Officer and principal accounting officer effective June 8, 2026, and Thuerk will stay on in a non-executive role until July 10, 2026 to support the handover.
Suzanne M. Thuerk gave notice of resignation on June 4, 2026, to pursue an opportunity outside the restaurant space.
Aaron M. Kale, age 49, was appointed Chief Accounting Officer and Vice President – Tax effective June 8, 2026.
Kale has been Vice President – Tax since April 2019 and has provided interim leadership of the accounting function since July 2025.
Thuerk will remain with the company in a non-executive capacity until July 10, 2026.
Matan Fattal resigned as a director and from the Audit, Compensation, and Nominating and Corporate Governance committees, effective June 5, 2026, and the filing says the resignation was not due to any disagreement with the company or its board. Following his departure, the company notified Nasdaq that it no longer meets audit committee and board independence requirements, and it intends to rely on cure periods while it searches for an independent director.
Matan Fattal resigned as director and from three board committees, effective June 5, 2026.
On June 8, 2026, the company notified Nasdaq that its audit committee no longer meets the three-member, independent-director requirement under Rule 5605(c)(2)(A).
The board now has two independent directors, two non-independent directors, and one vacant seat, so it no longer has an independent majority, a temporary noncompliance under Rule 5605(b).
The company intends to use Nasdaq cure periods and is searching for an independent director to join the board and audit committee.
Breeze Acquisition Corp. II, a blank check company, announced that its units will stop trading on June 11, 2026, and that its ordinary shares and rights will begin trading separately on the Nasdaq Global Market under the tickers BREZ and BREZR. The separation is mandatory and automatic, and unit holders take no action. The filing is administrative and does not change the company's business or the terms of its rights.
Units stop trading on June 11, 2026; ordinary shares (BREZ) and rights (BREZR) begin separate trading on Nasdaq Global Market
Each unit consists of one ordinary share and one right; each right entitles the holder to one-fifth of one ordinary share upon completion of an initial business combination
Holders must have five rights to receive one ordinary share; fractional shares are rounded down and not issued
At its June 9, 2026 annual meeting, Stifel Financial shareholders elected all twelve directors, approved an increase in authorized shares from 197,000,000 to 294,000,000, and approved adding 9,000,000 shares to the 2001 Incentive Stock Plan. The filing does not state the reasons for the share increases, but the authorized share increase and larger plan capacity could affect existing shareholders' ownership percentage if the shares are issued.
Authorized total shares rose from 197,000,000 to 294,000,000; common authorized shares rose from 194,000,000 to 291,000,000
Incentive Stock Plan capacity increased by 9,000,000 shares, including 175,000 reserved for non-employee directors, with 87,433,331 votes for and 38,926,563 against
Shareholders approved advisory say-on-pay, with 123,866,225 votes for and 2,396,358 against, and ratified KPMG LLP for 2026
On June 9, 2026, Micron's board appointed Alexis Black Björlin as an independent director and as a member of the Governance and Sustainability Committee. After the appointment, the board has nine directors, eight of them independent under Nasdaq rules. The filing discloses her director compensation but no financial results or other business effects.
Appointed to the board on June 9, 2026; the board now has nine directors, eight independent.
Joins the Governance and Sustainability Committee.
Compensation under the 2025 Director Compensation Plan includes a pro rata cash retainer for board service of $125,000 and a pro rata restricted stock grant valued at $250,000.
Currently Chief Strategy Officer at General Catalyst; previously senior vice president and general manager of DGX Cloud at NVIDIA.
Hershey's board appointed Joe Park, executive vice president and chief digital and information officer at State Farm, as a director effective June 29, 2026. The board determined he is independent under NYSE standards and he will sit on the Audit and Finance and Risk Management Committees.
Board appointment approved June 3, 2026, on the recommendation of the Governance Committee; effective June 29, 2026
Park has over 20 years of experience in digital transformation and technology strategy, including senior roles at Yum! Brands and Walmart
Park will join the Audit and Finance and Risk Management Committees and receive standard non-employee director compensation
Verde Clean Fuels, Inc. disclosed that director Martijn Dekker informed the board on June 3, 2026 that he is resigning, effective that same day. The filing does not state a reason for the resignation or name a successor, and it reports no financial results or other changes.
Martijn Dekker resigned as a director effective June 3, 2026.
He informed the Board of Directors of his resignation on June 3, 2026.
The filing does not give a reason for the resignation or name a replacement director.
Grocery Outlet appointed Ian Ferry as Executive Vice President, Chief Financial Officer and Treasurer, effective June 9, 2026, succeeding Christopher Miller, who leaves June 26, 2026. The company also named Paul Miller Executive Vice President, Chief Purchasing and Merchandising Officer, replacing Matthew Delly, who departs June 12, 2026, and affirmed its second quarter and fiscal 2026 outlook first provided May 13, 2026. The finance and purchasing leadership changes matter to shareholders because they reshape two senior roles, while the outlook was reaffirmed rather than changed.
Ian Ferry, 45, joined in June 2025 and becomes CFO with a $475,000 base salary and a target bonus of 60% of base salary.
Christopher Miller's departure is effective June 26, 2026; Matthew Delly's is effective June 12, 2026.
Paul Miller, a former Grocery Outlet executive who retired in 2024, returns full-time after serving as an advisor.
Susan Leary was promoted to Senior Vice President, Accounting and designated Principal Accounting Officer, with a $300,000 base salary.
Capital One filed a prospectus supplement that adds 39,843 shares of common stock to the resale registration for selling security holders who received them as consideration for the Brex Inc. acquisition, which closed April 7, 2026. The total shares the selling holders may offer rises to 10,385,749 from 10,345,906 previously. The filing is administrative and adds a modest number of shares that could enter the market.
Resale Prospectus Supplement No. 2 is dated June 9, 2026 and adds 39,843 shares.
Total registered for resale rises to 10,385,749 shares from 10,345,906 under the April 23, 2026 supplement.
Shares were issued to selling security holders as consideration for the Brex Inc. acquisition, which closed April 7, 2026.
On June 8, 2026, Virtu Financial Operating LLC, a subsidiary of Virtu Financial, Inc., entered into an amended and restated employment agreement with Chief Financial Officer Cindy Lee. The filing sets her base salary at $500,000 per year, adds a 20,000-share restricted stock or RSU special award, and sets severance terms that increase if a change in control occurs.
Base salary of $500,000 per year, with eligibility for a discretionary annual bonus
Special award of 20,000 restricted shares or RSUs, vesting in three equal annual installments
Initial term expires June 30, 2029, with automatic one-year renewals unless either party gives notice at least 90 days in advance
After a qualifying termination tied to a change in control, severance equals two and a half times base salary plus the most recent annual bonus, and benefits continue for 24 months or longer
At its June 5, 2026 annual meeting, Verrica Pharmaceuticals stockholders approved the Amended and Restated 2018 Equity Incentive Plan, which took effect immediately, and re-elected two directors. The filing shows all proposals passed, with shareholder votes on the equity plan and executive pay drawing more opposition than the other items.
Stockholders approved the Amended and Restated 2018 Equity Incentive Plan, with 11,142,881 votes for and 433,852 against
Paul B. Manning and Lawrence Eichenfield were elected as directors to serve until the 2029 annual meeting
Stockholders ratified KPMG LLP as the independent registered public accounting firm for fiscal 2026 with 14,058,234 votes for
14,069,331 shares, or 81.89% of the 17,178,786 shares outstanding on the record date, were present or represented at the meeting
At its June 5, 2026 annual meeting, Ligand Pharmaceuticals stockholders elected all eight director nominees to terms expiring in 2027 and approved an amended and restated 2002 Stock Incentive Plan. Stockholders also ratified Ernst & Young LLP as auditor for fiscal 2026 and approved a non-binding advisory vote on executive pay. The filing reports voting results only and does not report financial results.
All eight director nominees were elected, including Jason M. Aryeh, Todd C. Davis and Martine Zimmermann, Pharm.D.
Proposal 4 to approve the amended and restated 2002 Stock Incentive Plan passed with 16,643,281 votes for and 870,556 against.
Ernst & Young LLP was ratified as independent registered public accounting firm for the year ending December 31, 2026, with 18,526,515 votes for.
Non-binding say-on-pay proposal was approved with 16,497,712 votes for and 1,021,948 against.
STAAR Surgical's Compensation Committee approved a base salary increase for Deborah Andrews, its Interim Co-Chief Executive Officer and Chief Financial Officer, from $512,000 to $575,000, effective June 8, 2026. The committee also raised her target annual cash bonus from 55% to 60% of base salary, citing a review of competitive market pay data and her contributions to strategic and operational objectives.
Base salary rises from $512,000 to $575,000, effective June 8, 2026
Target annual cash bonus increases from 55% to 60% of base salary
Committee cited competitive market compensation data and Ms. Andrews' contributions to company objectives
CECO Environmental issued an initial full year 2026 outlook for the combined company after closing its acquisition of Thermon Group Holdings on June 1, 2026. The company expects revenue of $1.275 billion to $1.375 billion and Adjusted EBITDA of $195 million to $225 million, with guidance including seven months of Thermon contribution. Both measures are projected to rise about 20% and 25%, respectively, at the midpoints compared with the prior year.
Thermon acquisition closed June 1, 2026; guidance includes June through December contribution from Thermon.
Full year 2026 revenue expected between $1.275 billion and $1.375 billion, up about 20% at the midpoint year over year.
Adjusted EBITDA expected between $195 million and $225 million, up about 25% at the midpoint; free cash flow expected to be at least 55% of Adjusted EBITDA.
Management remains confident in generating $40 million or more in cost synergies.
CSP Inc. disclosed that Michael Newbanks, its Vice President of Finance and Chief Accounting Officer, left his position on June 5, 2026, after the company extended his role to help transfer it to Eric Sachs. The filing says the departure was not due to any disagreement with the company or its board, and Newbanks will provide consulting services going forward.
Michael Newbanks left his role as VP of Finance and Chief Accounting Officer on June 5, 2026.
Newbanks had served as Chief Accounting Officer since July 2017 and was Controller of the Modcomp subsidiary from May 2003.
The filing states the departure was not the result of any disagreement with the company or its board over operations, policies or practices.
Newbanks will provide consulting services to the company after his departure date.
Sherwin-Williams amended its credit agreement with Goldman Sachs Bank USA as administrative agent. The primary purpose is to extend the maturity of $200 million of borrowing and letter of credit commitments from June 20, 2026 to June 20, 2031.
Amendment No. 11 was entered into on June 9, 2026 with Goldman Sachs Bank USA as administrative agent and Goldman Sachs Mortgage Company as issuing bank.
$200 million of commitments now mature June 20, 2031, up from June 20, 2026.
The filing states that certain lenders and their affiliates have provided and may provide other financial services to the company, for which they receive customary fees.
Axiom Intelligence Acquisition Corp 1, a special purpose acquisition company, furnished an investor presentation tied to its May 25, 2026 Business Combination Agreement with Terra Quantum AG, a Swiss quantum technology company. The deck is preliminary, unaudited and states that it should not be relied on for investment decisions, so it gives shareholders company claims rather than verified results.
Business Combination Agreement signed May 25, 2026 with Terra Quantum AG, with Markus Pflitsch as representative for Company shareholders
Deck cites $200 million in SPAC IPO proceeds and a $1.3 trillion 2035 value creation opportunity for quantum computing, attributed to BCG and McKinsey
Deck says financial information was prepared for internal use, has not been audited or verified, and may not comply with IFRS or US GAAP; the filing says the combined company's Swiss parent, PubCo, must list on Nasdaq
Perma-Pipe reported first-quarter fiscal 2026 results for the quarter ended April 30, 2026. Net sales rose 7.5% to $50.3 million, but gross profit fell to $14.6 million from $16.7 million, and net income attributable to common stock fell to $1.8 million from $5.0 million, which management attributed partly to Middle East project delays and start-up costs. Management still expects revenue and net income growth for fiscal 2026 compared with fiscal 2025.
Net sales were $50.3 million, up from $46.7 million a year earlier, driven by higher volumes in North America and MENA.
Net income attributable to common stock was $1.8 million, versus $5.0 million; diluted EPS was $0.22, versus $0.61.
Backlog reached $136.5 million at April 30, 2026, up about 12% from $121.6 million at January 31, 2026.
Management said no projects have been cancelled and still expects revenue and net income growth for fiscal 2026.
Cibus, Inc. appointed Craig Wichner, a director since November 2025 and founder of Farmland LP, as Chief Executive Officer effective June 8, 2026, ending Peter Beetham's interim CEO role that began in February 2025. Both Wichner and Beetham resigned from the Board, and the authorized number of directors was reduced to seven. The filing discloses Wichner's pay package and a cut to Beetham's 2026 base salary, but it contains no financial results or guidance.
Wichner's employment agreement sets a base salary of $650,000, plus a discretionary annual bonus and annual incentive equity award.
Wichner received a restricted stock unit award and a stock option award, each with a grant date fair value of $1,100,000, vesting 25% annually over four years.
Beetham's 2026 base salary was reduced from $650,000 to $585,000 given his change in role.
Wichner's standard severance is 18 months of base salary; under a change in control it is 24 months.
Academy Sports and Outdoors reported first-quarter fiscal 2026 net sales of $1.44 billion, up 6.7%, and GAAP diluted EPS of $0.80, up 17.6%. The company raised the low end of its full-year guidance, lifting GAAP diluted EPS to $5.95 to $6.35 from $5.65 to $6.15, which benefits shareholders while management says it expects inflationary pressures to continue weighing on consumer spending.
Q1 net sales of $1.44 billion, up 6.7%; comparable sales up 2.9%
Q1 GAAP diluted EPS of $0.80, up 17.6%; adjusted diluted EPS of $0.93, up 22.4%
FY2026 GAAP diluted EPS guidance raised to $5.95-$6.35 from $5.65-$6.15; adjusted EPS guidance raised to $6.40-$6.80 from $6.10-$6.60
Quarterly dividend of $0.15 per share declared June 4, 2026, payable July 16, 2026 to holders of record on June 18, 2026
Quanterix appointed Jason Faessler as Chief Financial Officer and Treasurer, with employment expected to begin June 22, 2026. He previously led global FP&A and the Americas finance organization at Bruker Corporation, and the filing sets out his pay and severance terms.
Employment agreement dated May 31, 2026 provides an initial annualized base salary of $475,000 and a cash sign-on bonus of $200,000.
Annual bonus target of up to 50% of base salary.
Restricted stock units equal to 0.30% of common shares outstanding on his start date, vesting in four equal annual installments.
Severance includes 12 months of base salary and a pro-rated target bonus; full equity vesting applies if the termination is tied to a change in control.
Abundia Global Impact Group said it entered a long-term agreement with Frankfort Plastics to supply 40,000 tons per year of polyolefin plastic waste to its Cedar Port Waste to Fuels facility. The company says the volume is about 50% of the expected feedstock requirement for its first planned Cedar Port plant, but the filing does not disclose any financial terms or dollar value.
Frankfort Plastics committed to supply 40,000 tons per year for ten years, with an option for Abundia to buy additional volumes
The volume represents approximately 50% of the expected feedstock requirement for the first planned Cedar Port plant
Commercial terms are binding, with definitive agreements expected to be executed in 3Q 2026
The forward-looking statements cite liquidity needs, the need for additional financing, and going concern risk
SailPoint reported fiscal first quarter 2027 results for the period ended April 30, 2026, with total revenue up 22% year-over-year to $280 million and total ARR up 26% to $1,163 million. GAAP net loss narrowed to $74.7 million, or $(0.13) per share, from $187.3 million, or $(0.42) per share, a year earlier. For shareholders, the company also guided fiscal 2027 total revenue to $1,265 million to $1,275 million and adjusted EPS to $0.30 to $0.34.
Total revenue was $280 million, up 22% year-over-year; subscription revenue was $266 million, up 23%.
GAAP operating loss was $(80) million, compared with $(185) million in the prior-year quarter.
Operating cash flow was $38 million and free cash flow was $33 million.
Fiscal 2027 guidance: total revenue of $1,265 million to $1,275 million and adjusted EPS of $0.30 to $0.34.
Titan Machinery reported fiscal first-quarter 2027 results for the three months ended April 30, 2026. Revenue fell to $522.4 million from $594.3 million, while the net loss narrowed to $12.6 million, or $0.55 per diluted share, from $13.2 million, or $0.58 per share. The company reaffirmed its fiscal 2027 modeling assumptions, which include an adjusted diluted loss per share of ($1.25) to ($1.75), so shareholders see a smaller loss against weaker sales and continued expected losses for the year.
Revenue was $522.4 million versus $594.3 million a year earlier; Europe revenue fell 35.6% and Agriculture revenue fell 10.4%.
Net loss was $12.6 million, or $0.55 per diluted share, compared with a net loss of $13.2 million, or $0.58 per share.
Gross profit margin rose to 17.1% from 15.3%, while adjusted EBITDA was $1.0 million versus $2.6 million.
Fiscal 2027 guidance was reaffirmed, with adjusted diluted loss per share expected at ($1.25) to ($1.75); net cash used for operating activities was $23.1 million.
J.M. Smucker reported fourth-quarter fiscal 2026 net sales of $2.3 billion, up 6%, and adjusted earnings per share of $2.77, up 20%. For the full fiscal year, adjusted EPS fell 10% to $9.15 and the company posted a net loss of $1.30 per diluted share, while it guided fiscal 2027 net sales down 3.0% to 4.0% and adjusted EPS of $9.75 to $10.25.
Q4 net sales $2.3 billion (about $2,268.1 million), up 6%; adjusted EPS $2.77 vs. $2.31 a year earlier.
Q4 GAAP net income $3.64 per diluted share, compared with a net loss of $6.85 in the prior-year quarter, which included $867.3 million of goodwill impairment charges.
Fiscal 2026 net sales $9.1 billion, up 4%; net loss of $1.30 per diluted share; adjusted EPS $9.15, down 10%.
Fiscal 2027 outlook: net sales down 3.0% to 4.0%, adjusted EPS $9.75 to $10.25, free cash flow about $1.0 billion.
UNFI reported third-quarter fiscal 2026 results for the 13 weeks ended May 2, 2026. Net sales fell 4.2% to $7.7 billion, which the company said included about 450 basis points of impact from optimization actions, while net income rose to $33 million from a $7 million loss a year earlier. The company reiterated its full-year fiscal 2026 outlook midpoints and narrowed the ranges, and reported net leverage of 2.5x.
Net sales decreased 4.2% to $7.7 billion, including about 450 basis points of impact from optimization actions
Net income of $33 million, or $0.52 per diluted share, versus a net loss of $7 million, or $0.12 per share, a year earlier
Adjusted EBITDA rose 16.6% to $183 million; free cash flow was $54 million versus $119 million
Fiscal 2026 outlook midpoints reiterated for net sales, net income, EPS, Adjusted EBITDA and Adjusted EPS, with ranges narrowed
Designer Brands reported first quarter 2026 results for the quarter ended May 2, 2026, with net sales up 1.4% to $696.4 million and net income attributable to the company of $1.2 million, or $0.02 diluted EPS, compared with a loss of $17.8 million, or $0.37 per share, a year earlier. The company reaffirmed full-year 2026 diluted EPS guidance of $0.28 to $0.38 and said it expects EPS toward the high end of that range, while comparable sales fell 1.1%.
Net sales rose 1.4% to $696.4 million, but total comparable sales decreased 1.1%.
Gross margin expanded to 45.3% from 42.9%, and adjusted diluted EPS was $0.07 versus a loss of $0.27 a year earlier.
Full-year 2026 guidance was reaffirmed: net sales change of down 1% to up 1%, and diluted EPS of $0.28 to $0.38.
Cash and equivalents were $50.1 million and total debt was $475.3 million at the end of the quarter, down from $522.9 million a year earlier.
Novanta agreed on June 8, 2026 to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion in cash at closing, plus a $250 million milestone payment due by January 8, 2027. The deal is funded with cash on hand, existing credit facilities and a $300 million equity raise, and the credit agreement was amended to raise the permitted leverage ratio, which means more debt for shareholders to carry. The company expects the deal to close in the third quarter of 2026 and says it will update guidance after closing.
Purchase price of $1.2 billion in cash at closing, subject to customary adjustments, plus a $250 million milestone payment due on or before January 8, 2027
Financing from cash on hand, existing credit facilities and a recently completed $300 million equity raise
Credit agreement amended: permitted consolidated leverage ratio raised to 4.00 to 1.00, or 4.50 to 1.00 for four quarters after a designated acquisition
Expected net leverage of about 2.7x at closing in the third quarter of 2026, with a target below 2.3x by year-end 2027; standalone 2026 guidance was confirmed
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.